Abstract:Glaucoma filtration surgery is one of the most effective methods for lowering intraocular pressure in glaucoma. The surgery efficiently reduces intra-ocular pressure but the most common cause of failure is scarring at the incision site. This occurs in the conjunctiva/Tenon's capsule layer overlying the scleral coat of the eye. Currently used antimetabolite treatments to prevent post-surgical scarring are non-selective and are associated with potentially blinding side effects. Developing new treatments to target scarring requires both a better understanding of wound healing and scarring in the conjunctiva, and new means of delivering anti-scarring drugs locally and sustainably. By combining plastic compression of collagen gels with a soft collagen-based layer, we have developed a physiologically relevant model of the sub-epithelial bulbar conjunctiva/Tenon's capsule interface, which allows a more holistic approach to the understanding of subconjunctival tissue behaviour and local drug delivery. The biomimetic tissue hosts both primary human conjunctival fibroblasts and an immune component in the form of macrophages, morphologically and structurally mimicking the mechanical proprieties and contraction kinetics of ex vivo porcine conjunctiva. We show that our model is suitable for the screening of drugs targeting scarring and/or inflammation, and amenable to the study of local drug delivery devices that can be inserted in between the two layers of the biomimetic. We propose that this multicellular-bilayer engineered tissue will be useful to study complex biological aspects of scarring and fibrosis, including the role of inflammation, with potentially significant implications for the management of scarring following glaucoma filtration surgery and other anterior ocular segment scarring conditions. Crucially, it uniquely allows the evaluation of new means of local drug delivery within a physiologically relevant tissue mimetic, mimicking intraoperative drug delivery in vivo.

Research progress of medication strategy in the moduIation of wound heaIing after gIaucoma fiItration surgeries

Study on anti-cicatricial treatments for filtration canal after glaucoma surgery

An experimental study on homoharringtonine liposome and glaucoma filtration surgery.

Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis.

Recent advances in the phenotypic transition of cells after glaucoma filtration surgery

Evaluating the efficacy and safety of polyglycolic acid-loading mitomycin nanoparticles in inhibiting the scar proliferation after glaucoma filtering surgery

Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research

The Role of Vascular Endothelial Growth Factor and Bevacizumab on the Wound Healing in Trabeculectomy Patients

CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.

Inhibition of the Rapamycin-Insensitive Mtorc1 /4E-BP1 Axis Attenuates TGF-β1-induced Fibrotic Response in Human Tenon's Fibroblasts

Progresses of glaucoma surgery

Research progress on mechanism and medical prevention of refractive regression after laser myopia corneal refractive surgery

A Tenon’s capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery

Research progress for filtering blebs leakage after anti-glaucoma surgery

[Glaucoma Surgery in China: Problems and Solutions].

The Era of Minimally Invasive Glaucoma Surgery

A novel adjustable PHBV basement film for enhancing the efficacy of glaucoma surgery by inhibiting scar formation

SB-431542 Inhibition of Scar Formation after Filtration Surgery and Its Potential Mechanism.

How to Make an Appropriate Choice of Glaucoma Surgery

Management of peri-operation in anti-glaucoma surgery

Exploration and application of polyhydroxyalkanoates and polylactic acid membranes during glaucoma filtering surgery and interlaminar transplantation in rabbits